Mosquito-Borne Dengue Targeted by Antibody With Hope for Vaccine
This article is for subscribers only.
Scientists have discovered new antibodies that neutralize viruses that cause dengue, potentially putting a universal vaccine within reach for a mosquito-borne illness that strikes an estimated 400 million people a year.
The antibodies are effective against all four dengue viruses, according to an article published today in Nature Immunology. A vaccine being developed by Sanofi has had mixed results, helping to protect people from three of the viruses in one trial, and in all four in a bigger study.